跳至主要内容
临床试验/EUCTR2010-020599-47-DK
EUCTR2010-020599-47-DK进行中(未招募)1 期

The effect of Amiloride and Spironolacton on renophysiological and cardiovascular parametres in patients with hypertension - HASS

Departments of Medical Research and Medicine0 个研究点目标入组 25 人开始时间: 2010年5月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • hypertension: bloodpressure between 135/85 and 160/100
  • male and female
  • Age 45-70 years
  • BMI between 18,5-30,0 kg/m2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Secundary hypertension
  • Previous AMI, atrielfibrillation, heartdisease,cardiac-insufficiency.
  • Previous apoplexia
  • Lungdisease, liver disease, kidneydisease, hormone imbalances, brain
  • brain-disease or cancer
  • Alcoholabuse
  • Medical treatment exept contraceptives
  • Pregnancy or breastfeeding
  • Lack of wish to participate
  • Abnormal blood or urine samples
  • Abnormal ECG
  • Blooddonation within the last month

研究者

发起方
Departments of Medical Research and Medicine

相似试验